Martha Aronson named CEO of Merit Medical as Fred Lampropoulos resigns; remains Chairman

MERIT MEDICAL SYSTEMS INC

Aronson appointed President and CEO effective Oct 3, 2025; Lampropoulos resigns as CEO but stays as director and Chairman.
Aronson base salary $1M; signing bonus $250K; target bonus 100% of base; initial equity target $5.5M.
Immediate equity grant of $4.125M in PSUs and RSUs; transition allowance $12K/month through Sep 2026.
Lampropoulos serves as Executive Chairman through Jan 3, 2026, then non-employee director; consulting deal under negotiation.
Board expanded from 10 to 11 to accommodate Aronson's appointment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.